Bacterin presented preclinical results of an antimicrobial coating for orthopedic devices intended to reduce implant-associated infections at the 2014 Orthopaedic Trauma Association Annual Meeting.
Researchers at Bacterin have developed a rifampin-and minocycline-containing coating aimed at inhibiting microbial contamination of the implant. "Our testing has shown that the coating inhibits infection progression in a rabbit model of pin track infection and significantly aids orthopedic hardware in maintaining anchoring strength," said Mark Schallenberger, MS, the lead research scientist for the project and presenter of the findings at the meeting.
The antimicrobial coating has not yet received clearance from the U.S. Food and Drug Administration.
More articles on devices:
Medical start-up fundraising soars 28% in 2014 so far — 5 quick facts
10 things to know about Exactech's 3Q financial report — Net income drops 6%
Aurora Spine, Sentio sign distribution agreement for nerve mapping system